Global Secondary Progressive Multiple Sclerosis Drug Market Data Survey Report 2025
Summary
The global Secondary Progressive Multiple Sclerosis Drug market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Major Applications as follows:
Major Type as follows:
The global Secondary Progressive Multiple Sclerosis Drug market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- AB Science SA
- Actelion Ltd
- Biogen, Inc.
- F. Hoffmann-La Roche Ltd.
- Genzyme Corporation
- Glialogix, Inc.
- Glialogix, Inc.
- Innate Immunotherapeutics Ltd
- Kyorin Pharmaceutical Co., Ltd.
- Mallinckrodt Plc
- MedDay SA
- MedImmune, LLC
- Merck KGaA
- Meta-IQ ApS
- Novartis AG
- Opexa Therapeutics, Inc.
- Xenetic Biosciences (UK) Limited
Major Applications as follows:
- Hospital
- Clinic
- Others
Major Type as follows:
- Inebilizumab
- GLX-1112
- DC-TAB
- Etomoxir
- IB-MS
- Others
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 AB Science SA
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Actelion Ltd
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Biogen, Inc.
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 F. Hoffmann-La Roche Ltd.
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Genzyme Corporation
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Glialogix, Inc.
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Glialogix, Inc.
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Innate Immunotherapeutics Ltd
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Kyorin Pharmaceutical Co., Ltd.
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Mallinckrodt Plc
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 MedDay SA
3.12 MedImmune, LLC
3.13 Merck KGaA
3.14 Meta-IQ ApS
3.15 Novartis AG
3.16 Opexa Therapeutics, Inc.
3.17 Xenetic Biosciences (UK) Limited
4 MAJOR APPLICATION
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Clinic
4.2.1 Overview
4.2.2 Clinic Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET BY TYPE
5.1 Inebilizumab
5.1.1 Overview
5.1.2 Inebilizumab Market Size and Forecast
5.2 GLX-1112
5.2.1 Overview
5.2.2 GLX-1112 Market Size and Forecast
5.3 DC-TAB
5.3.1 Overview
5.3.2 DC-Tab Market Size and Forecast
5.4 Etomoxir
5.4.1 Overview
5.4.2 Etomoxir Market Size and Forecast
5.5 IB-MS
5.5.1 Overview
5.5.2 IB-MS Market Size and Forecast
5.6 IB-MS
5.6.1 Overview
5.6.2 IB-MS Market Size and Forecast
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 AB Science SA
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Actelion Ltd
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Biogen, Inc.
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 F. Hoffmann-La Roche Ltd.
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Genzyme Corporation
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Glialogix, Inc.
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Glialogix, Inc.
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Innate Immunotherapeutics Ltd
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Kyorin Pharmaceutical Co., Ltd.
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Mallinckrodt Plc
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 MedDay SA
3.12 MedImmune, LLC
3.13 Merck KGaA
3.14 Meta-IQ ApS
3.15 Novartis AG
3.16 Opexa Therapeutics, Inc.
3.17 Xenetic Biosciences (UK) Limited
4 MAJOR APPLICATION
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Clinic
4.2.1 Overview
4.2.2 Clinic Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET BY TYPE
5.1 Inebilizumab
5.1.1 Overview
5.1.2 Inebilizumab Market Size and Forecast
5.2 GLX-1112
5.2.1 Overview
5.2.2 GLX-1112 Market Size and Forecast
5.3 DC-TAB
5.3.1 Overview
5.3.2 DC-Tab Market Size and Forecast
5.4 Etomoxir
5.4.1 Overview
5.4.2 Etomoxir Market Size and Forecast
5.5 IB-MS
5.5.1 Overview
5.5.2 IB-MS Market Size and Forecast
5.6 IB-MS
5.6.1 Overview
5.6.2 IB-MS Market Size and Forecast
6 CONCLUSION
LIST OF TABLES
Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of AB Science SA
Tab Sales Revenue, Volume, Price, Cost and Margin of Actelion Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Biogen, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of Genzyme Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Glialogix, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Glialogix, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Innate Immunotherapeutics Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Kyorin Pharmaceutical Co., Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of Mallinckrodt Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of MedDay SA
Tab Sales Revenue, Volume, Price, Cost and Margin of MedImmune, LLC
Tab Sales Revenue, Volume, Price, Cost and Margin of Merck KGaA
Tab Sales Revenue, Volume, Price, Cost and Margin of Meta-IQ ApS
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Tab Sales Revenue, Volume, Price, Cost and Margin of Opexa Therapeutics, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Xenetic Biosciences (UK) Limited
Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of AB Science SA
Tab Sales Revenue, Volume, Price, Cost and Margin of Actelion Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Biogen, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of Genzyme Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Glialogix, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Glialogix, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Innate Immunotherapeutics Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Kyorin Pharmaceutical Co., Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of Mallinckrodt Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of MedDay SA
Tab Sales Revenue, Volume, Price, Cost and Margin of MedImmune, LLC
Tab Sales Revenue, Volume, Price, Cost and Margin of Merck KGaA
Tab Sales Revenue, Volume, Price, Cost and Margin of Meta-IQ ApS
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Tab Sales Revenue, Volume, Price, Cost and Margin of Opexa Therapeutics, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Xenetic Biosciences (UK) Limited
LIST OF FIGURES
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Size and CAGR 2011-2017 (Million USD)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Size and CAGR 2011-2017 (Volume)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2011-2017 (Million USD)
Fig Hospital Market Size and CAGR 2011-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Clinic Market Size and CAGR 2011-2017 (Million USD)
Fig Clinic Market Size and CAGR 2011-2017 (Volume)
Fig Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Fig Clinic Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Inebilizumab Market Size and CAGR 2011-2017 (Million USD)
Fig Inebilizumab Market Size and CAGR 2011-2017 (Volume)
Fig Inebilizumab Market Forecast and CAGR 2018-2025 (Million USD)
Fig Inebilizumab Market Forecast and CAGR 2018-2025 (Volume)
Fig GLX-1112 Market Size and CAGR 2011-2017 (Million USD)
Fig GLX-1112 Market Size and CAGR 2011-2017 (Volume)
Fig GLX-1112 Market Forecast and CAGR 2018-2025 (Million USD)
Fig GLX-1112 Market Forecast and CAGR 2018-2025 (Volume)
Fig DC-Tab Market Size and CAGR 2011-2017 (Million USD)
Fig DC-Tab Market Size and CAGR 2011-2017 (Volume)
Fig DC-Tab Market Forecast and CAGR 2018-2025 (Million USD)
Fig DC-Tab Market Forecast and CAGR 2018-2025 (Volume)
Fig Etomoxir Market Size and CAGR 2011-2017 (Million USD)
Fig Etomoxir Market Size and CAGR 2011-2017 (Volume)
Fig Etomoxir Market Forecast and CAGR 2018-2025 (Million USD)
Fig Etomoxir Market Forecast and CAGR 2018-2025 (Volume)
Fig IB-MS Market Size and CAGR 2011-2017 (Million USD)
Fig IB-MS Market Size and CAGR 2011-2017 (Volume)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Million USD)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Volume)
Fig IB-MS Market Size and CAGR 2011-2017 (Million USD)
Fig IB-MS Market Size and CAGR 2011-2017 (Volume)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Million USD)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Size and CAGR 2011-2017 (Million USD)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Size and CAGR 2011-2017 (Volume)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2011-2017 (Million USD)
Fig Hospital Market Size and CAGR 2011-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Clinic Market Size and CAGR 2011-2017 (Million USD)
Fig Clinic Market Size and CAGR 2011-2017 (Volume)
Fig Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Fig Clinic Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Inebilizumab Market Size and CAGR 2011-2017 (Million USD)
Fig Inebilizumab Market Size and CAGR 2011-2017 (Volume)
Fig Inebilizumab Market Forecast and CAGR 2018-2025 (Million USD)
Fig Inebilizumab Market Forecast and CAGR 2018-2025 (Volume)
Fig GLX-1112 Market Size and CAGR 2011-2017 (Million USD)
Fig GLX-1112 Market Size and CAGR 2011-2017 (Volume)
Fig GLX-1112 Market Forecast and CAGR 2018-2025 (Million USD)
Fig GLX-1112 Market Forecast and CAGR 2018-2025 (Volume)
Fig DC-Tab Market Size and CAGR 2011-2017 (Million USD)
Fig DC-Tab Market Size and CAGR 2011-2017 (Volume)
Fig DC-Tab Market Forecast and CAGR 2018-2025 (Million USD)
Fig DC-Tab Market Forecast and CAGR 2018-2025 (Volume)
Fig Etomoxir Market Size and CAGR 2011-2017 (Million USD)
Fig Etomoxir Market Size and CAGR 2011-2017 (Volume)
Fig Etomoxir Market Forecast and CAGR 2018-2025 (Million USD)
Fig Etomoxir Market Forecast and CAGR 2018-2025 (Volume)
Fig IB-MS Market Size and CAGR 2011-2017 (Million USD)
Fig IB-MS Market Size and CAGR 2011-2017 (Volume)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Million USD)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Volume)
Fig IB-MS Market Size and CAGR 2011-2017 (Million USD)
Fig IB-MS Market Size and CAGR 2011-2017 (Volume)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Million USD)
Fig IB-MS Market Forecast and CAGR 2018-2025 (Volume)
